What Has Been The Evolution of the Blood Transfusion Diagnostics Market in Recent Years?
The blood transfusion diagnostics market has seen considerable growth due to a variety of factors.
• In the past few years, the blood transfusion diagnostics market has experienced a swift expansion. The market size, which stood at $4.42 billion in 2024, is predicted to reach $4.96 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.2%.
This significant growth during the historical period is primarily linked with factors such as the rise in blood transfusion procedures, the emergence of new pathogens, an aging population, an escalation in the need for quick blood transfusion diagnostics, an increased prevalence of chronic illnesses, and a heightened demand for blood.
What Is the Forecasted Market Size and Growth Rate for The Blood Transfusion Diagnostics Market Size In The Coming Years?
The blood transfusion diagnostics market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the blood transfusion diagnostics market is projected to witness significant growth, escalating to a value of $6.43 billion by 2029, with a compound annual growth rate (CAGR) of 6.7%.
This upward trajectory during the forecast period is largely due to an increased need for precision medicine, increased funds towards blood transfusion infrastructure, a rising demand for molecular blood transfusions, the emergence of infectious diseases, and concerns related to blood safety. Some major trends to look out for during this forecast period are advancements in diagnostics, point-of-care testing, automated systems and robotics, nucleic acid testing (NAT), digital integration, broader pathogen panels, and enhanced testing technologies.
What Factors Are Driving Growth In The Blood Transfusion Diagnostics Market?
Patients who are in the process of having surgical procedures often require blood transfusions to compensate for the blood loss that occurs during this process. Before the transfusion, blood transfusion diagnostics are utilized to screen the blood to prevent the spread of infectious diseases. The US National Library of Medicine and National Institutes of Health reveal in an article that around 310 million surgeries are conducted each year. As a result, the surge in the number of these procedures heightens the demand for blood transfusion diagnostics.
What Are The Main Segments Of The Global Blood Transfusion Diagnostics Market?
The blood transfusion diagnostics market covered in this report is segmented –
1) By Type: Instruments and Kits, Reagents, Other Types
2) By Technology: Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test
3) By Application: Blood Grouping, Disease Screening
4) By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies
Subsegments:
1) By Instruments and Kits: Blood Typing Instruments, Cross-Matching Kits, Blood Screening Instruments, Automated Blood Processing Systems
2) By Reagents: Antisera, Control Solutions, Blood Grouping Reagents, Enzymes and Other Reagents
3) By Other Types: Software Solutions, Consumables, Training And Support Services
Pre-Book The Blood Transfusion Diagnostics Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing The Blood Transfusion Diagnostics Market?
The rising necessity for sophisticated diagnostic measures and the increasing occurrence of infectious diseases related to pathogens like bacteria and viruses have propelled the preference for nucleic acid amplification testing (NAAT/NAT) as a means to enhance blood safety, increase efficiency, and reduce the time needed for results. NAT is a method that allows detection of a specific nucleic acid, virus, or bacteria that serves as a pathogen in blood, tissue, or urine. Possessing high sensitivity and specificity for viral nucleic acids, NAT amplifies the targeted viral DNA region, thereby detecting these earlier than traditional methods and shortening the duration of infectious diseases. Illustratively, XCRP Diagnostic Inc. and Luminex Corporations formed a licensing agreement for utilizing XCR Diagnostic's Xtreme Chain Reaction Nucleic Acid Amplification Technology, granting Luminex exclusive rights to use XCR Diagnostic's NAAT technology in its upcoming molecular diagnostic portfolio.
Who Are the Key Players In The Blood Transfusion Diagnostics Market?
Major companies operating in the blood transfusion diagnostics market include:
• BAG Health Care GmbH
• Grifols S.A.
• Bio-Rad LaboratoriesInc.
• Abbott Laboratories
• Immucor Inc.
• Ortho Clinical Diagnostics
• DiaSorin S.p.A
• Siemens Healthineers
• Thermo Fisher Scientific Inc.
• Beckman Coulter Inc.
• Novartis AG
• F. Hoffmann-La Roche Ltd.
• bioMerieux
• Diagast SAS
• Fujirebio
• Biokit S.A.
• QuidelOrtho Corporation
• Danaher Corporation
• Becton Dickinson and Company
• Quotient Biodiagnostics
• Sekisui Diagnostics
• Sysmex Corporation
• Werfen S.A.
What Is The Most Dominant Region In The Blood Transfusion Diagnostics Market?
North America was the largest region in the blood transfusion diagnostics market in 2024. Western Europe was the second-largest region in the blood transfusion diagnostics industry. The regions covered in the blood transfusion diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
